Journal: EMBO Molecular Medicine

Article Title: An immunohistochemical atlas of necroptotic pathway expression

doi: 10.1038/s44321-024-00074-6

Figure Lengend Snippet: ( A ) To gauge immunohistochemistry performance, immunosignals from wild-type (WT) versus knockout (KO) tissue were deconvoluted, (i) pixel intensities plotted, (ii) ratioed to yield a signal-to-noise (S/N) histogram, and then (iii) integrated. ( B ) Heatmap shows relative integrated S/N values from seven automated immunohistochemistry protocols across seven tissues. Column headers indicate the antibody target clone name. Data were representative of n ≥ 3 for each target and tissue. ( C ) Heatmap depicts relative protein abundance values as SILAC (stable isotope labeling by amino acids in cell culture) ratios measured by (Geiger et al, ); the lowest value was assigned as 0.1 because 0 is below the detection limit. ( D ) Immunosignals of Caspase-8, RIPK1, RIPK3, and MLKL in wild-type versus the appropriate knockout (KO) tissue from Mlkl −/− or Casp8 − / − Ripk3 − / − or Casp8 −/ − Ripk1 −/ − Ripk3 − /− . Data were representative of n ≥ 3 for each target and tissue. Scale bars are 500 μm. Related to Appendix Fig. . .

Article Snippet: Rat anti-mouse RIPK3 , In-house clone 8G7; available from Millipore , Cat#MABC1595.

Techniques: Immunohistochemistry, Knock-Out, Labeling, Cell Culture

Journal: EMBO Molecular Medicine

Article Title: An immunohistochemical atlas of necroptotic pathway expression

doi: 10.1038/s44321-024-00074-6

Figure Lengend Snippet: ( A ) Immunosignals of Caspase-8, RIPK1, and RIPK3 from wild-type mouse ileum (i), colon (ii), liver (iii), and spleen (iv). The crypt base (crypt), villi/crypt tip (tip), central vein (CV), portal vein (PV), bile duct (BD), central artery (CA), white pulp (WP), marginal zone (MZ), and red pulp (RP) are annotated. Inset of immunostaining in the ileum shows lower RIPK3 expression in Paneth cells (open arrowhead) relative to neighboring cells. Arrow shows pericentral hepatocytes that express higher levels of Caspase-8. Closed arrowheads show Caspase-8 + RIPK1 + RIPK3 + Kupffer cells. Scale bars are 50 μm, except for the 10 μm scale bar in the inset. Data were representative of n ≥ 3 for each target and tissue. ( B ) Relative expression levels of Caspase-8, RIPK1, and RIPK3 (and splenic MLKL; Fig. ) along the indicated tissue axes. Red datapoints indicate immunosignal intensities, and the overlaid dark blue line indicating the LOWESS best-fit along N = 20 axes per tissue. Best-fit curves are superimposed in the left-most column. The dashed line indicates the boundary between the splenic white pulp and the marginal zone. Data were representative of n > 3 mice per target per tissue. ( C ) Scatterplots where each dot represents a different cell ontology from the Tabula Muris dataset (Tabula Muris et al, ). The percent of cells within each ontology that expressed Mki67 , Ripk1 , or Ripk3 was plotted against that of Top2a . Pearson correlation coefficient values are shown. Related to Fig. . .

Article Snippet: Rat anti-mouse RIPK3 , In-house clone 8G7; available from Millipore , Cat#MABC1595.

Techniques: Immunostaining, Expressing

Journal: EMBO Molecular Medicine

Article Title: An immunohistochemical atlas of necroptotic pathway expression

doi: 10.1038/s44321-024-00074-6

Figure Lengend Snippet: ( A ) Heatmap of cell ontologies from the Tabula Muris dataset (Tabula Muris et al, ). Left-most column depicts the tissue origin of each cell ontology. Other columns indicate the percent of cells within each ontology that expressed Top2a, Mki67 , Casp8 , Ripk1, Ripk3 , or Mlkl . Legend shows the color-to-tissue and the color-to-frequency scales. Cell ontologies of interest are annotated. ( B ) Micrograph of MLKL immunosignals from the wild-type mouse spleen. The white pulp (WP), marginal zone (MZ), and red pulp (RP) are annotated. Scale bar is 50 μm. Scatterplot shows relative expression levels of MLKL along the white pulp-to-red pulp axis. Red datapoints show immunosignal intensities and the overlaid dark blue line indicates the LOWESS best-fit along N = 20 axes from n = 1 mouse. Dashed line indicates the boundary between splenic white pulp and marginal zone. Data were representative of n > 3 mice. ( C , D ) Spatial transcriptomic data from (Moor et al, )) and (Ben-Moshe et al, ) showing the relative expression levels (arbitrary units; A.U.) of Caspase-8, RIPK1, RIPK3, or MLKL along the ileal crypt-to-villus axis ( C ) or the hepatic central vein-to-portal vein axis ( D ). ( E – G ) Spatial transcriptomic data on mouse spleen 12 days after Plasmodium berghei- infection. Panel ( E ) shows a uniform manifold approximation and projection (UMAP) of cell populations distinguished by unsupervised leiden clustering. Legend shows the color assigned to each population. Panel ( F ) shows the location of each cell cluster. Scale bar is 500 μm. Panel ( G ) shows the normalized expression for each gene product. Expression values for Casp8 , Ripk1 , Ripk3 , and Mlkl were summated to provide an index of “cluster pathway expression”, which was averaged to provide an index of “zone pathway expression”. Data were from n = 1 mouse.

Article Snippet: Rat anti-mouse RIPK3 , In-house clone 8G7; available from Millipore , Cat#MABC1595.

Techniques: Expressing, Infection

Journal: EMBO Molecular Medicine

Article Title: An immunohistochemical atlas of necroptotic pathway expression

doi: 10.1038/s44321-024-00074-6

Figure Lengend Snippet: ( A ) Experimental design. ( B ) Core temperatures of vehicle- and TNF-injected mice ( n = 3 mice per group). ( C ) Immunosignals for cleaved Caspase-3 (cl. C3), Caspase-8, RIPK1, or RIPK3 from the spleen of vehicle- or TNF-injected mice. Insets show unidentified RIPK1 high cells that associate with apoptotic bodies in the splenic white pulp. In panels ( C , E , G , I ), the scale bars in zoomed-out images correspond to 100 μm, and the scale bars in zoomed-in images correspond to 10 μm. ( D ) Graph of white pulp area occupied by cleaved Caspase-3 + material in vehicle- and TNF-treated mice. Each red datapoint represents one white pulp lobule ( N = 20 lobules/mouse). Blue datapoints indicate the median value per mouse ( n = 3 mice/treatment). Black bars represent the mean value per group. * p < 0.05 by unpaired two-tailed t -test. ( E ) RIPK3 immunosignals in the colon of vehicle- or TNF-treated mice. ( F ) Best-fit curves of RIPK3 immunosignals along the crypt-to-tip axis from N = 10 axes per mouse ( n = 3 mice/group). *** p < 0.001 by multiple unpaired two-tailed t -test. ( G ) RIPK3 (pink) and smooth muscle actin (brown) immunosignals in intestinal submucosa of vehicle- or TNF-treated mice. Insets show vessel cross-sections. Arrowheads show RIPK3 + endothelial cells (endo). ( H ) Plot of RIPK3 signals per vessel. Each red datapoint represents one vessel ( N = 50 vessels/mouse). Blue datapoints indicate the median value per mouse ( n = 3 mice/treatment). Black bars represent the mean value per group. * p < 0.05 by unpaired two-tailed t -test. ( I ) RIPK3 immunosignals in the liver of vehicle- or TNF-treated mice. Central vein (CV), portal vein (PV) and Kupffer cell (Kpf). ( J ) Plot of RIPK3 signals per hepatocyte or Kupffer cell. Each transparent datapoint represents one cell ( N = 90 cells/mouse). Opaque datapoints indicate the median value per mouse ( n = 3 mice/treatment). Black bars represent the mean value per group. * p < 0.05 and ** p < 0.01 by unpaired two-tailed t -test. ( K ) Core temperatures of vehicle-, TNF- and Nec1s+TNF-injected wild-type mice ( n = 4–5 mice/treatment; one dot/mouse/time). Line indicates mean. X indicates a euthanized mouse due to its body temperature being <30 °C. ( L ) RIPK3 levels in serum from the mice in panel ( K ) or from untreated Ripk3 -/- mice. Data expressed as arbitrary optical density units (A.U.). One dot per mouse. Mean ± SEM is shown. * p < 0.05, ** p < 0.01 by one-way ANOVA with Tukey’s post hoc correction. .

Article Snippet: Rat anti-mouse RIPK3 , In-house clone 8G7; available from Millipore , Cat#MABC1595.

Techniques: Injection, Two Tailed Test

Journal: EMBO Molecular Medicine

Article Title: An immunohistochemical atlas of necroptotic pathway expression

doi: 10.1038/s44321-024-00074-6

Figure Lengend Snippet: ( A ) Experimental design. ( B ) Bulk RNA sequencing was performed on indicated tissues. Heatmap depicts the log-fold-change in gene expression for antibiotic- versus water-treated mice. Each row represents a different mouse. The legend shows the color-to-value scale. ( C ) Immunoblots for the indicated proteins in the ileum and spleen of water- versus antibiotic-treated mice. Arrowheads indicate full-length proteins of interest. Coomassie staining of total protein content was used as a loading control. Data were representative of n = 7 mice per tissue per group. ( D ) Caspase-8, RIPK3, and RIPK3 immunosignals in the ileum of water- or antibiotic-treated mice. Arrowheads to cytosolic accumulations of RIPK1 and RIPK3 in epithelial cells at villi tips. Scale bars in lower magnification micrographs are 100 μm. Scale bars in insets are 10 μm. Data were representative of n = 7 mice per group. Related to Appendix Fig. . .

Article Snippet: Rat anti-mouse RIPK3 , In-house clone 8G7; available from Millipore , Cat#MABC1595.

Techniques: RNA Sequencing Assay, Expressing, Western Blot, Staining, Control

Journal: EMBO Molecular Medicine

Article Title: An immunohistochemical atlas of necroptotic pathway expression

doi: 10.1038/s44321-024-00074-6

Figure Lengend Snippet: ( A ) Experimental design. ( B ) Ki67, Caspase-8, RIPK1, RIPK3, and MLKL immunosignals from adjacent sections of the naïve or NP-KLH-immunized mouse spleen. Arrowheads show a Ki67 + germinal center that co-stains for RIPK3, but not other members of the pathway. Representative of n > 3 mice per group. Scale bars in lower magnification micrographs are 500 μm. Scale bars in insets are 100 μm. Data were representative of n > 3 mice per group. ( C – J ) Ripk3 -/- or Ripk3 +/+ mice were immunized with NP-KLH and circulating NP-specific IgG 1 ( C ), circulating NP-specific IgM ( D ), splenic mature B cells ( E , F ), splenic NP-specific plasma cells ( G ), circulating low affinity NP-specific IgG 1 antibody ( H ), circulating high affinity NP-specific IgG 1 ( I ), and the ratio between circulating low-and-high affinity NP-specific antibody ( J ) were measured at the indicated day after immunization. Bars on graphs in ( C – J ) represent mean ± SEM. Each datapoint represents one mouse. ns non-significant by two-sided t -test with Welch’s correction.

Article Snippet: Rat anti-mouse RIPK3 , In-house clone 8G7; available from Millipore , Cat#MABC1595.

Techniques:

Journal: EMBO Molecular Medicine

Article Title: An immunohistochemical atlas of necroptotic pathway expression

doi: 10.1038/s44321-024-00074-6

Figure Lengend Snippet: ( A ) Immunosignals of cleaved Caspase-3, Caspase-8, RIPK1, RIPK3, and MLKL in wild-type versus MLKL -/- or RIPK1 -/- , or CASP8 -/- CASP10 -/- MLKL -/- HT29 cells. Arrowheads indicate Caspase-8 + , RIPK1 + , RIPK3 + , and MLKL + puncta that are presumed to be necrosomes. Data were representative of n ≥ 2 for each protein and treatment. Scale bars in lower magnification micrographs are 10 μm. Scale bars in insets are 2 μm. ( B ) The percent of cells per treatment group that contain cytosolic necrosome-like puncta immunostained by the stipulated antibody. N = 1051–5630 cells were analysed per condition per stain. Data representative of n = 2 experiments. ( C ) The number of puncta per cell. N = 1000 cells per treatment group were analysed. Each datapoint represents one cell. The black bar indicates the mean value. **** p < 0.0001 by one-way ANOVA with Krukal–Wallis post hoc correction. Data representative of n = 2 experiments. Related to Appendix Figs. , and . .

Article Snippet: Rat anti-mouse RIPK3 , In-house clone 8G7; available from Millipore , Cat#MABC1595.

Techniques: Staining

Journal: EMBO Molecular Medicine

Article Title: An immunohistochemical atlas of necroptotic pathway expression

doi: 10.1038/s44321-024-00074-6

Figure Lengend Snippet: ( A ) Approach used to insert the human RIPK3 coding sequence (CDS) into the mouse Ripk3 locus. ( B ) Immunoblot of spleen homogenates from Ripk3 +/+ , Ripk3 -/- , human RIPK3 ( RIPK3 KI/KI ) or hemizygous human RIPK3 ( Ripk3 + RIPK3 KI ) mice. GAPDH immunoblots are shown as loading controls. Each lane represents a different mouse. ( C ) Immunosignals produced by the anti-human RIPK3 (clone 37A7F) or anti-mouse RIPK3 (clone 8G7) antibodies on spleen sections from RIPK3 KI/KI , Ripk3 +/+ or Casp8 -/- Ripk1 -/- Ripk3 -/- . Data were representative of n ≥ 3 for each target and tissue. Scale bars are 500 μm.

Article Snippet: Rat anti-mouse RIPK3 , In-house clone 8G7; available from Millipore , Cat#MABC1595.

Techniques: Sequencing, Western Blot, Produced

Journal: EMBO Molecular Medicine

Article Title: An immunohistochemical atlas of necroptotic pathway expression

doi: 10.1038/s44321-024-00074-6

Figure Lengend Snippet: ( A ) Study design. ( B ) Blinded histopathological (Robarts Histopathology Index; RHI) scores of disease activity in intestinal biopsies relative to their endoscopic grading of inflammation. Diamond indicates a sample that could not be formally scored, as it was solely comprised of neutrophilic exudate, but was given a pseudo-score of 15 that likely underrepresents the extent of disease activity in this biopsy. Biopsies scored in Panel B were matched to those used in panels ( C – E ) and Fig. (see Appendix Table for details). ( C ) Immunoblot of lysates from HT29 cells (red annotations) and intestinal biopsies from patients A-H (blue annotations). The fifth lane of each gel contained lysates from TSI-treated RIPK3 -/- or TSI-treated MLKL -/- cells (see source data for details). Patients A,C,E,G were non-IBD controls. Patients B and D had ulcerative colitis (UC). Patients F and H had Crohn’s disease (CD). The endoscopic grading of the biopsy site as “non-inflamed”, “marginally inflamed”, or “inflamed” is stipulated. Closed arrowheads indicate full-length form of proteins. Asterisks indicate active, phosphorylated forms of RIPK3 (pRIPK3) and MLKL (pMLKL). Open arrowheads indicate active, cleaved forms of Caspase-8, Caspase-10, and Caspase-3. GAPDH was used as a loading control. ( D ) Immunohistochemistry for Caspase-8 (clone B.925.8) on intestinal biopsies. Insets a–e show diffuse epithelial Caspase-8 in patient C. Insets f–j show mild clustering of epithelial Caspase-8 and insets k–o show more pronounced clustering of epithelial Caspase-8 in patient D (arrowheads). Scale bars in lower magnification micrographs are 500 μm. Scale bars in insets are 10 μm. ( E ) The number of Caspase-8 + puncta per 100 cells. Each datapoint represents one crypt. Whole slide scans with N = 20,246 cells from the ‘non-IBD patient C’ biopsy, N = 10,416 cells from the ‘non-inflamed patient D’ biopsy, and N = 30,799 cells from the ‘inflamed patient D’ biopsy were analysed. The black bar indicates the mean value. ** p < 0.01 by one-way ANOVA with Tukey’s post hoc correction. Related to Appendix Table Figs. 5; Appendix Fig. . .

Article Snippet: Rat anti-mouse RIPK3 , In-house clone 8G7; available from Millipore , Cat#MABC1595.

Techniques: Histopathology, Activity Assay, Western Blot, Control, Immunohistochemistry

Journal: EMBO Molecular Medicine

Article Title: An immunohistochemical atlas of necroptotic pathway expression

doi: 10.1038/s44321-024-00074-6

Figure Lengend Snippet: Immunoblot of lysates from HT29 cells (red annotations) and intestinal biopsies from patients A-H (blue annotations). The fifth lane of each gel contained lysates from TSI-treated RIPK3 -/- or TSI-treated MLKL -/- cells (see source data for details). Patient J was a non-IBD control. Patient I had ulcerative colitis (UC). The endoscopic grading of the biopsy site as “non-inflamed”, “marginally inflamed”, or “inflamed” is stipulated. Closed arrowheads indicate full-length form of proteins. Asterisks indicate active, phosphorylated forms of RIPK3 (pRIPK3) and MLKL (pMLKL). Open arrowheads indicate active, cleaved forms of Caspase-10 and Caspase-3. GAPDH was used as a loading control.

Article Snippet: Rat anti-mouse RIPK3 , In-house clone 8G7; available from Millipore , Cat#MABC1595.

Techniques: Western Blot, Control

Journal: EMBO Molecular Medicine

Article Title: An immunohistochemical atlas of necroptotic pathway expression

doi: 10.1038/s44321-024-00074-6

Figure Lengend Snippet: Immunohistochemistry for cleaved Caspase-3, Caspase-8 (clone B.925.8), RIPK1, RIPK3, and MLKL (clone EPR171514) on intestinal biopsies from the stipulated patients. Four representative micrographs per biopsy are shown (i-v). Open arrowheads indicate instances of epithelial apoptosis. Closed arrowheads indicate instances of epithelial Caspase-8 clustering. Scale bars are 10 μm. The location for each micrograph within the biopsy is indicated in Appendix Fig. .

Article Snippet: Rat anti-mouse RIPK3 , In-house clone 8G7; available from Millipore , Cat#MABC1595.

Techniques: Immunohistochemistry

Journal: EMBO Molecular Medicine

Article Title: An immunohistochemical atlas of necroptotic pathway expression

doi: 10.1038/s44321-024-00074-6

Figure Lengend Snippet: Reagents and tools table

Article Snippet: Rat anti-mouse RIPK3 , In-house clone 8G7; available from Millipore , Cat#MABC1595.

Techniques: Derivative Assay, Polymer, Plasmid Preparation, Blocking Assay, Membrane, Staining, RNA HS Assay, dsDNA Assay, Protease Inhibitor, Software, Imaging, Enzyme-linked Immunosorbent Assay

Journal: EMBO Molecular Medicine

Article Title: An immunohistochemical atlas of necroptotic pathway expression

doi: 10.1038/s44321-024-00074-6

Figure Lengend Snippet: ( A ) To gauge immunohistochemistry performance, immunosignals from wild-type (WT) versus knockout (KO) tissue were deconvoluted, (i) pixel intensities plotted, (ii) ratioed to yield a signal-to-noise (S/N) histogram, and then (iii) integrated. ( B ) Heatmap shows relative integrated S/N values from seven automated immunohistochemistry protocols across seven tissues. Column headers indicate the antibody target clone name. Data were representative of n ≥ 3 for each target and tissue. ( C ) Heatmap depicts relative protein abundance values as SILAC (stable isotope labeling by amino acids in cell culture) ratios measured by (Geiger et al, ); the lowest value was assigned as 0.1 because 0 is below the detection limit. ( D ) Immunosignals of Caspase-8, RIPK1, RIPK3, and MLKL in wild-type versus the appropriate knockout (KO) tissue from Mlkl −/− or Casp8 − / − Ripk3 − / − or Casp8 −/ − Ripk1 −/ − Ripk3 − /− . Data were representative of n ≥ 3 for each target and tissue. Scale bars are 500 μm. Related to Appendix Fig. . .

Article Snippet: Optimal dilutions were determined for the following primary antibodies with the corresponding Autostainer protocols established in this study presented in Appendix Table : rat anti-mouse Caspase-8 (clone 3B10; RRID:AB_2490519; 1 g/L produced in-house (O’Reilly et al, ) and available from AdipoGen Cat#AG-20T-0138), 1:200 working dilution; rat anti-mouse Caspase-8 (clone 1G12; RRID:AB_2490518; 1 g/L produced in-house (O’Reilly et al, ) and available from AdipoGen Cat#AG-20T-0137), 1:200 dilution; rabbit anti-Caspase-8 (clone D35G2; RRID:AB_10545768; Cell Signaling Technology Cat#4790), 1:200 dilution; rabbit anti-RIPK1 (clone D94C12; RRID:AB_2305314; Cell Signaling Technology Cat#3493), 1:200 dilution; rat anti-mouse RIPK3 (clone 1H12; 2 g/L produced in-house (Samson et al, )), 1:100 dilution; rat anti-mouse RIPK3 (clone 8G7; RRID: RRID:AB_2940810; 2 g/L produced in-house (Petrie et al, ) and available from Millipore Cat#MABC1595), 1:500 dilution; rat anti-mouse MLKL (clone 5A6; RRID:AB_2940800; 50 g/L produced in-house (Samson et al, ) and available from Millipore Cat#MABC1634), 1:200 dilution; mouse anti-human Caspase-8 (clone B.925.8; RRID:AB_10978471; 0.619 g/L Thermo Fisher Scientific Cat# MA5-15226), 1:50; rabbit anti-human RIPK3 (clone E7A7F; RRID:AB_2904619; Cell Signaling Technology Cat# 10188), 1:100 dilution; rat anti-human MLKL (clone 10C2; RRID:AB_2940821; 2 g/L produced in-house (Samson et al, ) and available from Millipore Cat# MABC1635), 1:500 dilution; rabbit anti-human MLKL (clone EPR17514; RRID:AB_2755030; 1.9 g/L; Abcam Cat# ab184718), 1:500 dilution; rabbit anti-smooth muscle actin (clone D4K9N; RRID:AB_2734735; Cell Signaling Technology Cat#9245 S), 1:300 dilution; rabbit anti-cleaved-caspase-3 (Cell Signaling Technology, #9661), 1:300 dilution; rabbit anti-Ki67 (Cell Signaling Technology, #12202), 1:400 dilution.

Techniques: Immunohistochemistry, Knock-Out, Labeling, Cell Culture

Journal: EMBO Molecular Medicine

Article Title: An immunohistochemical atlas of necroptotic pathway expression

doi: 10.1038/s44321-024-00074-6

Figure Lengend Snippet: ( A ) Immunosignals of Caspase-8, RIPK1, and RIPK3 from wild-type mouse ileum (i), colon (ii), liver (iii), and spleen (iv). The crypt base (crypt), villi/crypt tip (tip), central vein (CV), portal vein (PV), bile duct (BD), central artery (CA), white pulp (WP), marginal zone (MZ), and red pulp (RP) are annotated. Inset of immunostaining in the ileum shows lower RIPK3 expression in Paneth cells (open arrowhead) relative to neighboring cells. Arrow shows pericentral hepatocytes that express higher levels of Caspase-8. Closed arrowheads show Caspase-8 + RIPK1 + RIPK3 + Kupffer cells. Scale bars are 50 μm, except for the 10 μm scale bar in the inset. Data were representative of n ≥ 3 for each target and tissue. ( B ) Relative expression levels of Caspase-8, RIPK1, and RIPK3 (and splenic MLKL; Fig. ) along the indicated tissue axes. Red datapoints indicate immunosignal intensities, and the overlaid dark blue line indicating the LOWESS best-fit along N = 20 axes per tissue. Best-fit curves are superimposed in the left-most column. The dashed line indicates the boundary between the splenic white pulp and the marginal zone. Data were representative of n > 3 mice per target per tissue. ( C ) Scatterplots where each dot represents a different cell ontology from the Tabula Muris dataset (Tabula Muris et al, ). The percent of cells within each ontology that expressed Mki67 , Ripk1 , or Ripk3 was plotted against that of Top2a . Pearson correlation coefficient values are shown. Related to Fig. . .

Article Snippet: Optimal dilutions were determined for the following primary antibodies with the corresponding Autostainer protocols established in this study presented in Appendix Table : rat anti-mouse Caspase-8 (clone 3B10; RRID:AB_2490519; 1 g/L produced in-house (O’Reilly et al, ) and available from AdipoGen Cat#AG-20T-0138), 1:200 working dilution; rat anti-mouse Caspase-8 (clone 1G12; RRID:AB_2490518; 1 g/L produced in-house (O’Reilly et al, ) and available from AdipoGen Cat#AG-20T-0137), 1:200 dilution; rabbit anti-Caspase-8 (clone D35G2; RRID:AB_10545768; Cell Signaling Technology Cat#4790), 1:200 dilution; rabbit anti-RIPK1 (clone D94C12; RRID:AB_2305314; Cell Signaling Technology Cat#3493), 1:200 dilution; rat anti-mouse RIPK3 (clone 1H12; 2 g/L produced in-house (Samson et al, )), 1:100 dilution; rat anti-mouse RIPK3 (clone 8G7; RRID: RRID:AB_2940810; 2 g/L produced in-house (Petrie et al, ) and available from Millipore Cat#MABC1595), 1:500 dilution; rat anti-mouse MLKL (clone 5A6; RRID:AB_2940800; 50 g/L produced in-house (Samson et al, ) and available from Millipore Cat#MABC1634), 1:200 dilution; mouse anti-human Caspase-8 (clone B.925.8; RRID:AB_10978471; 0.619 g/L Thermo Fisher Scientific Cat# MA5-15226), 1:50; rabbit anti-human RIPK3 (clone E7A7F; RRID:AB_2904619; Cell Signaling Technology Cat# 10188), 1:100 dilution; rat anti-human MLKL (clone 10C2; RRID:AB_2940821; 2 g/L produced in-house (Samson et al, ) and available from Millipore Cat# MABC1635), 1:500 dilution; rabbit anti-human MLKL (clone EPR17514; RRID:AB_2755030; 1.9 g/L; Abcam Cat# ab184718), 1:500 dilution; rabbit anti-smooth muscle actin (clone D4K9N; RRID:AB_2734735; Cell Signaling Technology Cat#9245 S), 1:300 dilution; rabbit anti-cleaved-caspase-3 (Cell Signaling Technology, #9661), 1:300 dilution; rabbit anti-Ki67 (Cell Signaling Technology, #12202), 1:400 dilution.

Techniques: Immunostaining, Expressing

Journal: EMBO Molecular Medicine

Article Title: An immunohistochemical atlas of necroptotic pathway expression

doi: 10.1038/s44321-024-00074-6

Figure Lengend Snippet: ( A ) Heatmap of cell ontologies from the Tabula Muris dataset (Tabula Muris et al, ). Left-most column depicts the tissue origin of each cell ontology. Other columns indicate the percent of cells within each ontology that expressed Top2a, Mki67 , Casp8 , Ripk1, Ripk3 , or Mlkl . Legend shows the color-to-tissue and the color-to-frequency scales. Cell ontologies of interest are annotated. ( B ) Micrograph of MLKL immunosignals from the wild-type mouse spleen. The white pulp (WP), marginal zone (MZ), and red pulp (RP) are annotated. Scale bar is 50 μm. Scatterplot shows relative expression levels of MLKL along the white pulp-to-red pulp axis. Red datapoints show immunosignal intensities and the overlaid dark blue line indicates the LOWESS best-fit along N = 20 axes from n = 1 mouse. Dashed line indicates the boundary between splenic white pulp and marginal zone. Data were representative of n > 3 mice. ( C , D ) Spatial transcriptomic data from (Moor et al, )) and (Ben-Moshe et al, ) showing the relative expression levels (arbitrary units; A.U.) of Caspase-8, RIPK1, RIPK3, or MLKL along the ileal crypt-to-villus axis ( C ) or the hepatic central vein-to-portal vein axis ( D ). ( E – G ) Spatial transcriptomic data on mouse spleen 12 days after Plasmodium berghei- infection. Panel ( E ) shows a uniform manifold approximation and projection (UMAP) of cell populations distinguished by unsupervised leiden clustering. Legend shows the color assigned to each population. Panel ( F ) shows the location of each cell cluster. Scale bar is 500 μm. Panel ( G ) shows the normalized expression for each gene product. Expression values for Casp8 , Ripk1 , Ripk3 , and Mlkl were summated to provide an index of “cluster pathway expression”, which was averaged to provide an index of “zone pathway expression”. Data were from n = 1 mouse.

Article Snippet: Optimal dilutions were determined for the following primary antibodies with the corresponding Autostainer protocols established in this study presented in Appendix Table : rat anti-mouse Caspase-8 (clone 3B10; RRID:AB_2490519; 1 g/L produced in-house (O’Reilly et al, ) and available from AdipoGen Cat#AG-20T-0138), 1:200 working dilution; rat anti-mouse Caspase-8 (clone 1G12; RRID:AB_2490518; 1 g/L produced in-house (O’Reilly et al, ) and available from AdipoGen Cat#AG-20T-0137), 1:200 dilution; rabbit anti-Caspase-8 (clone D35G2; RRID:AB_10545768; Cell Signaling Technology Cat#4790), 1:200 dilution; rabbit anti-RIPK1 (clone D94C12; RRID:AB_2305314; Cell Signaling Technology Cat#3493), 1:200 dilution; rat anti-mouse RIPK3 (clone 1H12; 2 g/L produced in-house (Samson et al, )), 1:100 dilution; rat anti-mouse RIPK3 (clone 8G7; RRID: RRID:AB_2940810; 2 g/L produced in-house (Petrie et al, ) and available from Millipore Cat#MABC1595), 1:500 dilution; rat anti-mouse MLKL (clone 5A6; RRID:AB_2940800; 50 g/L produced in-house (Samson et al, ) and available from Millipore Cat#MABC1634), 1:200 dilution; mouse anti-human Caspase-8 (clone B.925.8; RRID:AB_10978471; 0.619 g/L Thermo Fisher Scientific Cat# MA5-15226), 1:50; rabbit anti-human RIPK3 (clone E7A7F; RRID:AB_2904619; Cell Signaling Technology Cat# 10188), 1:100 dilution; rat anti-human MLKL (clone 10C2; RRID:AB_2940821; 2 g/L produced in-house (Samson et al, ) and available from Millipore Cat# MABC1635), 1:500 dilution; rabbit anti-human MLKL (clone EPR17514; RRID:AB_2755030; 1.9 g/L; Abcam Cat# ab184718), 1:500 dilution; rabbit anti-smooth muscle actin (clone D4K9N; RRID:AB_2734735; Cell Signaling Technology Cat#9245 S), 1:300 dilution; rabbit anti-cleaved-caspase-3 (Cell Signaling Technology, #9661), 1:300 dilution; rabbit anti-Ki67 (Cell Signaling Technology, #12202), 1:400 dilution.

Techniques: Expressing, Infection

Journal: EMBO Molecular Medicine

Article Title: An immunohistochemical atlas of necroptotic pathway expression

doi: 10.1038/s44321-024-00074-6

Figure Lengend Snippet: ( A ) Experimental design. ( B ) Core temperatures of vehicle- and TNF-injected mice ( n = 3 mice per group). ( C ) Immunosignals for cleaved Caspase-3 (cl. C3), Caspase-8, RIPK1, or RIPK3 from the spleen of vehicle- or TNF-injected mice. Insets show unidentified RIPK1 high cells that associate with apoptotic bodies in the splenic white pulp. In panels ( C , E , G , I ), the scale bars in zoomed-out images correspond to 100 μm, and the scale bars in zoomed-in images correspond to 10 μm. ( D ) Graph of white pulp area occupied by cleaved Caspase-3 + material in vehicle- and TNF-treated mice. Each red datapoint represents one white pulp lobule ( N = 20 lobules/mouse). Blue datapoints indicate the median value per mouse ( n = 3 mice/treatment). Black bars represent the mean value per group. * p < 0.05 by unpaired two-tailed t -test. ( E ) RIPK3 immunosignals in the colon of vehicle- or TNF-treated mice. ( F ) Best-fit curves of RIPK3 immunosignals along the crypt-to-tip axis from N = 10 axes per mouse ( n = 3 mice/group). *** p < 0.001 by multiple unpaired two-tailed t -test. ( G ) RIPK3 (pink) and smooth muscle actin (brown) immunosignals in intestinal submucosa of vehicle- or TNF-treated mice. Insets show vessel cross-sections. Arrowheads show RIPK3 + endothelial cells (endo). ( H ) Plot of RIPK3 signals per vessel. Each red datapoint represents one vessel ( N = 50 vessels/mouse). Blue datapoints indicate the median value per mouse ( n = 3 mice/treatment). Black bars represent the mean value per group. * p < 0.05 by unpaired two-tailed t -test. ( I ) RIPK3 immunosignals in the liver of vehicle- or TNF-treated mice. Central vein (CV), portal vein (PV) and Kupffer cell (Kpf). ( J ) Plot of RIPK3 signals per hepatocyte or Kupffer cell. Each transparent datapoint represents one cell ( N = 90 cells/mouse). Opaque datapoints indicate the median value per mouse ( n = 3 mice/treatment). Black bars represent the mean value per group. * p < 0.05 and ** p < 0.01 by unpaired two-tailed t -test. ( K ) Core temperatures of vehicle-, TNF- and Nec1s+TNF-injected wild-type mice ( n = 4–5 mice/treatment; one dot/mouse/time). Line indicates mean. X indicates a euthanized mouse due to its body temperature being <30 °C. ( L ) RIPK3 levels in serum from the mice in panel ( K ) or from untreated Ripk3 -/- mice. Data expressed as arbitrary optical density units (A.U.). One dot per mouse. Mean ± SEM is shown. * p < 0.05, ** p < 0.01 by one-way ANOVA with Tukey’s post hoc correction. .

Article Snippet: Optimal dilutions were determined for the following primary antibodies with the corresponding Autostainer protocols established in this study presented in Appendix Table : rat anti-mouse Caspase-8 (clone 3B10; RRID:AB_2490519; 1 g/L produced in-house (O’Reilly et al, ) and available from AdipoGen Cat#AG-20T-0138), 1:200 working dilution; rat anti-mouse Caspase-8 (clone 1G12; RRID:AB_2490518; 1 g/L produced in-house (O’Reilly et al, ) and available from AdipoGen Cat#AG-20T-0137), 1:200 dilution; rabbit anti-Caspase-8 (clone D35G2; RRID:AB_10545768; Cell Signaling Technology Cat#4790), 1:200 dilution; rabbit anti-RIPK1 (clone D94C12; RRID:AB_2305314; Cell Signaling Technology Cat#3493), 1:200 dilution; rat anti-mouse RIPK3 (clone 1H12; 2 g/L produced in-house (Samson et al, )), 1:100 dilution; rat anti-mouse RIPK3 (clone 8G7; RRID: RRID:AB_2940810; 2 g/L produced in-house (Petrie et al, ) and available from Millipore Cat#MABC1595), 1:500 dilution; rat anti-mouse MLKL (clone 5A6; RRID:AB_2940800; 50 g/L produced in-house (Samson et al, ) and available from Millipore Cat#MABC1634), 1:200 dilution; mouse anti-human Caspase-8 (clone B.925.8; RRID:AB_10978471; 0.619 g/L Thermo Fisher Scientific Cat# MA5-15226), 1:50; rabbit anti-human RIPK3 (clone E7A7F; RRID:AB_2904619; Cell Signaling Technology Cat# 10188), 1:100 dilution; rat anti-human MLKL (clone 10C2; RRID:AB_2940821; 2 g/L produced in-house (Samson et al, ) and available from Millipore Cat# MABC1635), 1:500 dilution; rabbit anti-human MLKL (clone EPR17514; RRID:AB_2755030; 1.9 g/L; Abcam Cat# ab184718), 1:500 dilution; rabbit anti-smooth muscle actin (clone D4K9N; RRID:AB_2734735; Cell Signaling Technology Cat#9245 S), 1:300 dilution; rabbit anti-cleaved-caspase-3 (Cell Signaling Technology, #9661), 1:300 dilution; rabbit anti-Ki67 (Cell Signaling Technology, #12202), 1:400 dilution.

Techniques: Injection, Two Tailed Test

Journal: EMBO Molecular Medicine

Article Title: An immunohistochemical atlas of necroptotic pathway expression

doi: 10.1038/s44321-024-00074-6

Figure Lengend Snippet: ( A ) Experimental design. ( B ) Bulk RNA sequencing was performed on indicated tissues. Heatmap depicts the log-fold-change in gene expression for antibiotic- versus water-treated mice. Each row represents a different mouse. The legend shows the color-to-value scale. ( C ) Immunoblots for the indicated proteins in the ileum and spleen of water- versus antibiotic-treated mice. Arrowheads indicate full-length proteins of interest. Coomassie staining of total protein content was used as a loading control. Data were representative of n = 7 mice per tissue per group. ( D ) Caspase-8, RIPK3, and RIPK3 immunosignals in the ileum of water- or antibiotic-treated mice. Arrowheads to cytosolic accumulations of RIPK1 and RIPK3 in epithelial cells at villi tips. Scale bars in lower magnification micrographs are 100 μm. Scale bars in insets are 10 μm. Data were representative of n = 7 mice per group. Related to Appendix Fig. . .

Article Snippet: Optimal dilutions were determined for the following primary antibodies with the corresponding Autostainer protocols established in this study presented in Appendix Table : rat anti-mouse Caspase-8 (clone 3B10; RRID:AB_2490519; 1 g/L produced in-house (O’Reilly et al, ) and available from AdipoGen Cat#AG-20T-0138), 1:200 working dilution; rat anti-mouse Caspase-8 (clone 1G12; RRID:AB_2490518; 1 g/L produced in-house (O’Reilly et al, ) and available from AdipoGen Cat#AG-20T-0137), 1:200 dilution; rabbit anti-Caspase-8 (clone D35G2; RRID:AB_10545768; Cell Signaling Technology Cat#4790), 1:200 dilution; rabbit anti-RIPK1 (clone D94C12; RRID:AB_2305314; Cell Signaling Technology Cat#3493), 1:200 dilution; rat anti-mouse RIPK3 (clone 1H12; 2 g/L produced in-house (Samson et al, )), 1:100 dilution; rat anti-mouse RIPK3 (clone 8G7; RRID: RRID:AB_2940810; 2 g/L produced in-house (Petrie et al, ) and available from Millipore Cat#MABC1595), 1:500 dilution; rat anti-mouse MLKL (clone 5A6; RRID:AB_2940800; 50 g/L produced in-house (Samson et al, ) and available from Millipore Cat#MABC1634), 1:200 dilution; mouse anti-human Caspase-8 (clone B.925.8; RRID:AB_10978471; 0.619 g/L Thermo Fisher Scientific Cat# MA5-15226), 1:50; rabbit anti-human RIPK3 (clone E7A7F; RRID:AB_2904619; Cell Signaling Technology Cat# 10188), 1:100 dilution; rat anti-human MLKL (clone 10C2; RRID:AB_2940821; 2 g/L produced in-house (Samson et al, ) and available from Millipore Cat# MABC1635), 1:500 dilution; rabbit anti-human MLKL (clone EPR17514; RRID:AB_2755030; 1.9 g/L; Abcam Cat# ab184718), 1:500 dilution; rabbit anti-smooth muscle actin (clone D4K9N; RRID:AB_2734735; Cell Signaling Technology Cat#9245 S), 1:300 dilution; rabbit anti-cleaved-caspase-3 (Cell Signaling Technology, #9661), 1:300 dilution; rabbit anti-Ki67 (Cell Signaling Technology, #12202), 1:400 dilution.

Techniques: RNA Sequencing Assay, Expressing, Western Blot, Staining, Control

Journal: EMBO Molecular Medicine

Article Title: An immunohistochemical atlas of necroptotic pathway expression

doi: 10.1038/s44321-024-00074-6

Figure Lengend Snippet: ( A ) Experimental design. ( B ) Ki67, Caspase-8, RIPK1, RIPK3, and MLKL immunosignals from adjacent sections of the naïve or NP-KLH-immunized mouse spleen. Arrowheads show a Ki67 + germinal center that co-stains for RIPK3, but not other members of the pathway. Representative of n > 3 mice per group. Scale bars in lower magnification micrographs are 500 μm. Scale bars in insets are 100 μm. Data were representative of n > 3 mice per group. ( C – J ) Ripk3 -/- or Ripk3 +/+ mice were immunized with NP-KLH and circulating NP-specific IgG 1 ( C ), circulating NP-specific IgM ( D ), splenic mature B cells ( E , F ), splenic NP-specific plasma cells ( G ), circulating low affinity NP-specific IgG 1 antibody ( H ), circulating high affinity NP-specific IgG 1 ( I ), and the ratio between circulating low-and-high affinity NP-specific antibody ( J ) were measured at the indicated day after immunization. Bars on graphs in ( C – J ) represent mean ± SEM. Each datapoint represents one mouse. ns non-significant by two-sided t -test with Welch’s correction.

Article Snippet: Optimal dilutions were determined for the following primary antibodies with the corresponding Autostainer protocols established in this study presented in Appendix Table : rat anti-mouse Caspase-8 (clone 3B10; RRID:AB_2490519; 1 g/L produced in-house (O’Reilly et al, ) and available from AdipoGen Cat#AG-20T-0138), 1:200 working dilution; rat anti-mouse Caspase-8 (clone 1G12; RRID:AB_2490518; 1 g/L produced in-house (O’Reilly et al, ) and available from AdipoGen Cat#AG-20T-0137), 1:200 dilution; rabbit anti-Caspase-8 (clone D35G2; RRID:AB_10545768; Cell Signaling Technology Cat#4790), 1:200 dilution; rabbit anti-RIPK1 (clone D94C12; RRID:AB_2305314; Cell Signaling Technology Cat#3493), 1:200 dilution; rat anti-mouse RIPK3 (clone 1H12; 2 g/L produced in-house (Samson et al, )), 1:100 dilution; rat anti-mouse RIPK3 (clone 8G7; RRID: RRID:AB_2940810; 2 g/L produced in-house (Petrie et al, ) and available from Millipore Cat#MABC1595), 1:500 dilution; rat anti-mouse MLKL (clone 5A6; RRID:AB_2940800; 50 g/L produced in-house (Samson et al, ) and available from Millipore Cat#MABC1634), 1:200 dilution; mouse anti-human Caspase-8 (clone B.925.8; RRID:AB_10978471; 0.619 g/L Thermo Fisher Scientific Cat# MA5-15226), 1:50; rabbit anti-human RIPK3 (clone E7A7F; RRID:AB_2904619; Cell Signaling Technology Cat# 10188), 1:100 dilution; rat anti-human MLKL (clone 10C2; RRID:AB_2940821; 2 g/L produced in-house (Samson et al, ) and available from Millipore Cat# MABC1635), 1:500 dilution; rabbit anti-human MLKL (clone EPR17514; RRID:AB_2755030; 1.9 g/L; Abcam Cat# ab184718), 1:500 dilution; rabbit anti-smooth muscle actin (clone D4K9N; RRID:AB_2734735; Cell Signaling Technology Cat#9245 S), 1:300 dilution; rabbit anti-cleaved-caspase-3 (Cell Signaling Technology, #9661), 1:300 dilution; rabbit anti-Ki67 (Cell Signaling Technology, #12202), 1:400 dilution.

Techniques:

Journal: EMBO Molecular Medicine

Article Title: An immunohistochemical atlas of necroptotic pathway expression

doi: 10.1038/s44321-024-00074-6

Figure Lengend Snippet: ( A ) Immunosignals of cleaved Caspase-3, Caspase-8, RIPK1, RIPK3, and MLKL in wild-type versus MLKL -/- or RIPK1 -/- , or CASP8 -/- CASP10 -/- MLKL -/- HT29 cells. Arrowheads indicate Caspase-8 + , RIPK1 + , RIPK3 + , and MLKL + puncta that are presumed to be necrosomes. Data were representative of n ≥ 2 for each protein and treatment. Scale bars in lower magnification micrographs are 10 μm. Scale bars in insets are 2 μm. ( B ) The percent of cells per treatment group that contain cytosolic necrosome-like puncta immunostained by the stipulated antibody. N = 1051–5630 cells were analysed per condition per stain. Data representative of n = 2 experiments. ( C ) The number of puncta per cell. N = 1000 cells per treatment group were analysed. Each datapoint represents one cell. The black bar indicates the mean value. **** p < 0.0001 by one-way ANOVA with Krukal–Wallis post hoc correction. Data representative of n = 2 experiments. Related to Appendix Figs. , and . .

Article Snippet: Optimal dilutions were determined for the following primary antibodies with the corresponding Autostainer protocols established in this study presented in Appendix Table : rat anti-mouse Caspase-8 (clone 3B10; RRID:AB_2490519; 1 g/L produced in-house (O’Reilly et al, ) and available from AdipoGen Cat#AG-20T-0138), 1:200 working dilution; rat anti-mouse Caspase-8 (clone 1G12; RRID:AB_2490518; 1 g/L produced in-house (O’Reilly et al, ) and available from AdipoGen Cat#AG-20T-0137), 1:200 dilution; rabbit anti-Caspase-8 (clone D35G2; RRID:AB_10545768; Cell Signaling Technology Cat#4790), 1:200 dilution; rabbit anti-RIPK1 (clone D94C12; RRID:AB_2305314; Cell Signaling Technology Cat#3493), 1:200 dilution; rat anti-mouse RIPK3 (clone 1H12; 2 g/L produced in-house (Samson et al, )), 1:100 dilution; rat anti-mouse RIPK3 (clone 8G7; RRID: RRID:AB_2940810; 2 g/L produced in-house (Petrie et al, ) and available from Millipore Cat#MABC1595), 1:500 dilution; rat anti-mouse MLKL (clone 5A6; RRID:AB_2940800; 50 g/L produced in-house (Samson et al, ) and available from Millipore Cat#MABC1634), 1:200 dilution; mouse anti-human Caspase-8 (clone B.925.8; RRID:AB_10978471; 0.619 g/L Thermo Fisher Scientific Cat# MA5-15226), 1:50; rabbit anti-human RIPK3 (clone E7A7F; RRID:AB_2904619; Cell Signaling Technology Cat# 10188), 1:100 dilution; rat anti-human MLKL (clone 10C2; RRID:AB_2940821; 2 g/L produced in-house (Samson et al, ) and available from Millipore Cat# MABC1635), 1:500 dilution; rabbit anti-human MLKL (clone EPR17514; RRID:AB_2755030; 1.9 g/L; Abcam Cat# ab184718), 1:500 dilution; rabbit anti-smooth muscle actin (clone D4K9N; RRID:AB_2734735; Cell Signaling Technology Cat#9245 S), 1:300 dilution; rabbit anti-cleaved-caspase-3 (Cell Signaling Technology, #9661), 1:300 dilution; rabbit anti-Ki67 (Cell Signaling Technology, #12202), 1:400 dilution.

Techniques: Staining

Journal: EMBO Molecular Medicine

Article Title: An immunohistochemical atlas of necroptotic pathway expression

doi: 10.1038/s44321-024-00074-6

Figure Lengend Snippet: ( A ) Approach used to insert the human RIPK3 coding sequence (CDS) into the mouse Ripk3 locus. ( B ) Immunoblot of spleen homogenates from Ripk3 +/+ , Ripk3 -/- , human RIPK3 ( RIPK3 KI/KI ) or hemizygous human RIPK3 ( Ripk3 + RIPK3 KI ) mice. GAPDH immunoblots are shown as loading controls. Each lane represents a different mouse. ( C ) Immunosignals produced by the anti-human RIPK3 (clone 37A7F) or anti-mouse RIPK3 (clone 8G7) antibodies on spleen sections from RIPK3 KI/KI , Ripk3 +/+ or Casp8 -/- Ripk1 -/- Ripk3 -/- . Data were representative of n ≥ 3 for each target and tissue. Scale bars are 500 μm.

Article Snippet: Optimal dilutions were determined for the following primary antibodies with the corresponding Autostainer protocols established in this study presented in Appendix Table : rat anti-mouse Caspase-8 (clone 3B10; RRID:AB_2490519; 1 g/L produced in-house (O’Reilly et al, ) and available from AdipoGen Cat#AG-20T-0138), 1:200 working dilution; rat anti-mouse Caspase-8 (clone 1G12; RRID:AB_2490518; 1 g/L produced in-house (O’Reilly et al, ) and available from AdipoGen Cat#AG-20T-0137), 1:200 dilution; rabbit anti-Caspase-8 (clone D35G2; RRID:AB_10545768; Cell Signaling Technology Cat#4790), 1:200 dilution; rabbit anti-RIPK1 (clone D94C12; RRID:AB_2305314; Cell Signaling Technology Cat#3493), 1:200 dilution; rat anti-mouse RIPK3 (clone 1H12; 2 g/L produced in-house (Samson et al, )), 1:100 dilution; rat anti-mouse RIPK3 (clone 8G7; RRID: RRID:AB_2940810; 2 g/L produced in-house (Petrie et al, ) and available from Millipore Cat#MABC1595), 1:500 dilution; rat anti-mouse MLKL (clone 5A6; RRID:AB_2940800; 50 g/L produced in-house (Samson et al, ) and available from Millipore Cat#MABC1634), 1:200 dilution; mouse anti-human Caspase-8 (clone B.925.8; RRID:AB_10978471; 0.619 g/L Thermo Fisher Scientific Cat# MA5-15226), 1:50; rabbit anti-human RIPK3 (clone E7A7F; RRID:AB_2904619; Cell Signaling Technology Cat# 10188), 1:100 dilution; rat anti-human MLKL (clone 10C2; RRID:AB_2940821; 2 g/L produced in-house (Samson et al, ) and available from Millipore Cat# MABC1635), 1:500 dilution; rabbit anti-human MLKL (clone EPR17514; RRID:AB_2755030; 1.9 g/L; Abcam Cat# ab184718), 1:500 dilution; rabbit anti-smooth muscle actin (clone D4K9N; RRID:AB_2734735; Cell Signaling Technology Cat#9245 S), 1:300 dilution; rabbit anti-cleaved-caspase-3 (Cell Signaling Technology, #9661), 1:300 dilution; rabbit anti-Ki67 (Cell Signaling Technology, #12202), 1:400 dilution.

Techniques: Sequencing, Western Blot, Produced

Journal: EMBO Molecular Medicine

Article Title: An immunohistochemical atlas of necroptotic pathway expression

doi: 10.1038/s44321-024-00074-6

Figure Lengend Snippet: ( A ) Study design. ( B ) Blinded histopathological (Robarts Histopathology Index; RHI) scores of disease activity in intestinal biopsies relative to their endoscopic grading of inflammation. Diamond indicates a sample that could not be formally scored, as it was solely comprised of neutrophilic exudate, but was given a pseudo-score of 15 that likely underrepresents the extent of disease activity in this biopsy. Biopsies scored in Panel B were matched to those used in panels ( C – E ) and Fig. (see Appendix Table for details). ( C ) Immunoblot of lysates from HT29 cells (red annotations) and intestinal biopsies from patients A-H (blue annotations). The fifth lane of each gel contained lysates from TSI-treated RIPK3 -/- or TSI-treated MLKL -/- cells (see source data for details). Patients A,C,E,G were non-IBD controls. Patients B and D had ulcerative colitis (UC). Patients F and H had Crohn’s disease (CD). The endoscopic grading of the biopsy site as “non-inflamed”, “marginally inflamed”, or “inflamed” is stipulated. Closed arrowheads indicate full-length form of proteins. Asterisks indicate active, phosphorylated forms of RIPK3 (pRIPK3) and MLKL (pMLKL). Open arrowheads indicate active, cleaved forms of Caspase-8, Caspase-10, and Caspase-3. GAPDH was used as a loading control. ( D ) Immunohistochemistry for Caspase-8 (clone B.925.8) on intestinal biopsies. Insets a–e show diffuse epithelial Caspase-8 in patient C. Insets f–j show mild clustering of epithelial Caspase-8 and insets k–o show more pronounced clustering of epithelial Caspase-8 in patient D (arrowheads). Scale bars in lower magnification micrographs are 500 μm. Scale bars in insets are 10 μm. ( E ) The number of Caspase-8 + puncta per 100 cells. Each datapoint represents one crypt. Whole slide scans with N = 20,246 cells from the ‘non-IBD patient C’ biopsy, N = 10,416 cells from the ‘non-inflamed patient D’ biopsy, and N = 30,799 cells from the ‘inflamed patient D’ biopsy were analysed. The black bar indicates the mean value. ** p < 0.01 by one-way ANOVA with Tukey’s post hoc correction. Related to Appendix Table Figs. 5; Appendix Fig. . .

Article Snippet: Optimal dilutions were determined for the following primary antibodies with the corresponding Autostainer protocols established in this study presented in Appendix Table : rat anti-mouse Caspase-8 (clone 3B10; RRID:AB_2490519; 1 g/L produced in-house (O’Reilly et al, ) and available from AdipoGen Cat#AG-20T-0138), 1:200 working dilution; rat anti-mouse Caspase-8 (clone 1G12; RRID:AB_2490518; 1 g/L produced in-house (O’Reilly et al, ) and available from AdipoGen Cat#AG-20T-0137), 1:200 dilution; rabbit anti-Caspase-8 (clone D35G2; RRID:AB_10545768; Cell Signaling Technology Cat#4790), 1:200 dilution; rabbit anti-RIPK1 (clone D94C12; RRID:AB_2305314; Cell Signaling Technology Cat#3493), 1:200 dilution; rat anti-mouse RIPK3 (clone 1H12; 2 g/L produced in-house (Samson et al, )), 1:100 dilution; rat anti-mouse RIPK3 (clone 8G7; RRID: RRID:AB_2940810; 2 g/L produced in-house (Petrie et al, ) and available from Millipore Cat#MABC1595), 1:500 dilution; rat anti-mouse MLKL (clone 5A6; RRID:AB_2940800; 50 g/L produced in-house (Samson et al, ) and available from Millipore Cat#MABC1634), 1:200 dilution; mouse anti-human Caspase-8 (clone B.925.8; RRID:AB_10978471; 0.619 g/L Thermo Fisher Scientific Cat# MA5-15226), 1:50; rabbit anti-human RIPK3 (clone E7A7F; RRID:AB_2904619; Cell Signaling Technology Cat# 10188), 1:100 dilution; rat anti-human MLKL (clone 10C2; RRID:AB_2940821; 2 g/L produced in-house (Samson et al, ) and available from Millipore Cat# MABC1635), 1:500 dilution; rabbit anti-human MLKL (clone EPR17514; RRID:AB_2755030; 1.9 g/L; Abcam Cat# ab184718), 1:500 dilution; rabbit anti-smooth muscle actin (clone D4K9N; RRID:AB_2734735; Cell Signaling Technology Cat#9245 S), 1:300 dilution; rabbit anti-cleaved-caspase-3 (Cell Signaling Technology, #9661), 1:300 dilution; rabbit anti-Ki67 (Cell Signaling Technology, #12202), 1:400 dilution.

Techniques: Histopathology, Activity Assay, Western Blot, Control, Immunohistochemistry

Journal: EMBO Molecular Medicine

Article Title: An immunohistochemical atlas of necroptotic pathway expression

doi: 10.1038/s44321-024-00074-6

Figure Lengend Snippet: Immunoblot of lysates from HT29 cells (red annotations) and intestinal biopsies from patients A-H (blue annotations). The fifth lane of each gel contained lysates from TSI-treated RIPK3 -/- or TSI-treated MLKL -/- cells (see source data for details). Patient J was a non-IBD control. Patient I had ulcerative colitis (UC). The endoscopic grading of the biopsy site as “non-inflamed”, “marginally inflamed”, or “inflamed” is stipulated. Closed arrowheads indicate full-length form of proteins. Asterisks indicate active, phosphorylated forms of RIPK3 (pRIPK3) and MLKL (pMLKL). Open arrowheads indicate active, cleaved forms of Caspase-10 and Caspase-3. GAPDH was used as a loading control.

Article Snippet: Optimal dilutions were determined for the following primary antibodies with the corresponding Autostainer protocols established in this study presented in Appendix Table : rat anti-mouse Caspase-8 (clone 3B10; RRID:AB_2490519; 1 g/L produced in-house (O’Reilly et al, ) and available from AdipoGen Cat#AG-20T-0138), 1:200 working dilution; rat anti-mouse Caspase-8 (clone 1G12; RRID:AB_2490518; 1 g/L produced in-house (O’Reilly et al, ) and available from AdipoGen Cat#AG-20T-0137), 1:200 dilution; rabbit anti-Caspase-8 (clone D35G2; RRID:AB_10545768; Cell Signaling Technology Cat#4790), 1:200 dilution; rabbit anti-RIPK1 (clone D94C12; RRID:AB_2305314; Cell Signaling Technology Cat#3493), 1:200 dilution; rat anti-mouse RIPK3 (clone 1H12; 2 g/L produced in-house (Samson et al, )), 1:100 dilution; rat anti-mouse RIPK3 (clone 8G7; RRID: RRID:AB_2940810; 2 g/L produced in-house (Petrie et al, ) and available from Millipore Cat#MABC1595), 1:500 dilution; rat anti-mouse MLKL (clone 5A6; RRID:AB_2940800; 50 g/L produced in-house (Samson et al, ) and available from Millipore Cat#MABC1634), 1:200 dilution; mouse anti-human Caspase-8 (clone B.925.8; RRID:AB_10978471; 0.619 g/L Thermo Fisher Scientific Cat# MA5-15226), 1:50; rabbit anti-human RIPK3 (clone E7A7F; RRID:AB_2904619; Cell Signaling Technology Cat# 10188), 1:100 dilution; rat anti-human MLKL (clone 10C2; RRID:AB_2940821; 2 g/L produced in-house (Samson et al, ) and available from Millipore Cat# MABC1635), 1:500 dilution; rabbit anti-human MLKL (clone EPR17514; RRID:AB_2755030; 1.9 g/L; Abcam Cat# ab184718), 1:500 dilution; rabbit anti-smooth muscle actin (clone D4K9N; RRID:AB_2734735; Cell Signaling Technology Cat#9245 S), 1:300 dilution; rabbit anti-cleaved-caspase-3 (Cell Signaling Technology, #9661), 1:300 dilution; rabbit anti-Ki67 (Cell Signaling Technology, #12202), 1:400 dilution.

Techniques: Western Blot, Control

Journal: EMBO Molecular Medicine

Article Title: An immunohistochemical atlas of necroptotic pathway expression

doi: 10.1038/s44321-024-00074-6

Figure Lengend Snippet: Immunohistochemistry for cleaved Caspase-3, Caspase-8 (clone B.925.8), RIPK1, RIPK3, and MLKL (clone EPR171514) on intestinal biopsies from the stipulated patients. Four representative micrographs per biopsy are shown (i-v). Open arrowheads indicate instances of epithelial apoptosis. Closed arrowheads indicate instances of epithelial Caspase-8 clustering. Scale bars are 10 μm. The location for each micrograph within the biopsy is indicated in Appendix Fig. .

Article Snippet: Optimal dilutions were determined for the following primary antibodies with the corresponding Autostainer protocols established in this study presented in Appendix Table : rat anti-mouse Caspase-8 (clone 3B10; RRID:AB_2490519; 1 g/L produced in-house (O’Reilly et al, ) and available from AdipoGen Cat#AG-20T-0138), 1:200 working dilution; rat anti-mouse Caspase-8 (clone 1G12; RRID:AB_2490518; 1 g/L produced in-house (O’Reilly et al, ) and available from AdipoGen Cat#AG-20T-0137), 1:200 dilution; rabbit anti-Caspase-8 (clone D35G2; RRID:AB_10545768; Cell Signaling Technology Cat#4790), 1:200 dilution; rabbit anti-RIPK1 (clone D94C12; RRID:AB_2305314; Cell Signaling Technology Cat#3493), 1:200 dilution; rat anti-mouse RIPK3 (clone 1H12; 2 g/L produced in-house (Samson et al, )), 1:100 dilution; rat anti-mouse RIPK3 (clone 8G7; RRID: RRID:AB_2940810; 2 g/L produced in-house (Petrie et al, ) and available from Millipore Cat#MABC1595), 1:500 dilution; rat anti-mouse MLKL (clone 5A6; RRID:AB_2940800; 50 g/L produced in-house (Samson et al, ) and available from Millipore Cat#MABC1634), 1:200 dilution; mouse anti-human Caspase-8 (clone B.925.8; RRID:AB_10978471; 0.619 g/L Thermo Fisher Scientific Cat# MA5-15226), 1:50; rabbit anti-human RIPK3 (clone E7A7F; RRID:AB_2904619; Cell Signaling Technology Cat# 10188), 1:100 dilution; rat anti-human MLKL (clone 10C2; RRID:AB_2940821; 2 g/L produced in-house (Samson et al, ) and available from Millipore Cat# MABC1635), 1:500 dilution; rabbit anti-human MLKL (clone EPR17514; RRID:AB_2755030; 1.9 g/L; Abcam Cat# ab184718), 1:500 dilution; rabbit anti-smooth muscle actin (clone D4K9N; RRID:AB_2734735; Cell Signaling Technology Cat#9245 S), 1:300 dilution; rabbit anti-cleaved-caspase-3 (Cell Signaling Technology, #9661), 1:300 dilution; rabbit anti-Ki67 (Cell Signaling Technology, #12202), 1:400 dilution.

Techniques: Immunohistochemistry

Journal: EMBO Molecular Medicine

Article Title: An immunohistochemical atlas of necroptotic pathway expression

doi: 10.1038/s44321-024-00074-6

Figure Lengend Snippet: Reagents and tools table

Article Snippet: Optimal dilutions were determined for the following primary antibodies with the corresponding Autostainer protocols established in this study presented in Appendix Table : rat anti-mouse Caspase-8 (clone 3B10; RRID:AB_2490519; 1 g/L produced in-house (O’Reilly et al, ) and available from AdipoGen Cat#AG-20T-0138), 1:200 working dilution; rat anti-mouse Caspase-8 (clone 1G12; RRID:AB_2490518; 1 g/L produced in-house (O’Reilly et al, ) and available from AdipoGen Cat#AG-20T-0137), 1:200 dilution; rabbit anti-Caspase-8 (clone D35G2; RRID:AB_10545768; Cell Signaling Technology Cat#4790), 1:200 dilution; rabbit anti-RIPK1 (clone D94C12; RRID:AB_2305314; Cell Signaling Technology Cat#3493), 1:200 dilution; rat anti-mouse RIPK3 (clone 1H12; 2 g/L produced in-house (Samson et al, )), 1:100 dilution; rat anti-mouse RIPK3 (clone 8G7; RRID: RRID:AB_2940810; 2 g/L produced in-house (Petrie et al, ) and available from Millipore Cat#MABC1595), 1:500 dilution; rat anti-mouse MLKL (clone 5A6; RRID:AB_2940800; 50 g/L produced in-house (Samson et al, ) and available from Millipore Cat#MABC1634), 1:200 dilution; mouse anti-human Caspase-8 (clone B.925.8; RRID:AB_10978471; 0.619 g/L Thermo Fisher Scientific Cat# MA5-15226), 1:50; rabbit anti-human RIPK3 (clone E7A7F; RRID:AB_2904619; Cell Signaling Technology Cat# 10188), 1:100 dilution; rat anti-human MLKL (clone 10C2; RRID:AB_2940821; 2 g/L produced in-house (Samson et al, ) and available from Millipore Cat# MABC1635), 1:500 dilution; rabbit anti-human MLKL (clone EPR17514; RRID:AB_2755030; 1.9 g/L; Abcam Cat# ab184718), 1:500 dilution; rabbit anti-smooth muscle actin (clone D4K9N; RRID:AB_2734735; Cell Signaling Technology Cat#9245 S), 1:300 dilution; rabbit anti-cleaved-caspase-3 (Cell Signaling Technology, #9661), 1:300 dilution; rabbit anti-Ki67 (Cell Signaling Technology, #12202), 1:400 dilution.

Techniques: Derivative Assay, Polymer, Plasmid Preparation, Blocking Assay, Membrane, Staining, RNA HS Assay, dsDNA Assay, Protease Inhibitor, Software, Imaging, Enzyme-linked Immunosorbent Assay

Journal: EMBO Molecular Medicine

Article Title: An immunohistochemical atlas of necroptotic pathway expression

doi: 10.1038/s44321-024-00074-6

Figure Lengend Snippet: ( A ) To gauge immunohistochemistry performance, immunosignals from wild-type (WT) versus knockout (KO) tissue were deconvoluted, (i) pixel intensities plotted, (ii) ratioed to yield a signal-to-noise (S/N) histogram, and then (iii) integrated. ( B ) Heatmap shows relative integrated S/N values from seven automated immunohistochemistry protocols across seven tissues. Column headers indicate the antibody target clone name. Data were representative of n ≥ 3 for each target and tissue. ( C ) Heatmap depicts relative protein abundance values as SILAC (stable isotope labeling by amino acids in cell culture) ratios measured by (Geiger et al, ); the lowest value was assigned as 0.1 because 0 is below the detection limit. ( D ) Immunosignals of Caspase-8, RIPK1, RIPK3, and MLKL in wild-type versus the appropriate knockout (KO) tissue from Mlkl −/− or Casp8 − / − Ripk3 − / − or Casp8 −/ − Ripk1 −/ − Ripk3 − /− . Data were representative of n ≥ 3 for each target and tissue. Scale bars are 500 μm. Related to Appendix Fig. . .

Article Snippet: Rat anti-mouse RIPK3 biotin-conjugated , This study , Derived from in-house clone 8G7 (available as Millipore Cat#MABC1595).

Techniques: Immunohistochemistry, Knock-Out, Labeling, Cell Culture

Journal: EMBO Molecular Medicine

Article Title: An immunohistochemical atlas of necroptotic pathway expression

doi: 10.1038/s44321-024-00074-6

Figure Lengend Snippet: ( A ) Immunosignals of Caspase-8, RIPK1, and RIPK3 from wild-type mouse ileum (i), colon (ii), liver (iii), and spleen (iv). The crypt base (crypt), villi/crypt tip (tip), central vein (CV), portal vein (PV), bile duct (BD), central artery (CA), white pulp (WP), marginal zone (MZ), and red pulp (RP) are annotated. Inset of immunostaining in the ileum shows lower RIPK3 expression in Paneth cells (open arrowhead) relative to neighboring cells. Arrow shows pericentral hepatocytes that express higher levels of Caspase-8. Closed arrowheads show Caspase-8 + RIPK1 + RIPK3 + Kupffer cells. Scale bars are 50 μm, except for the 10 μm scale bar in the inset. Data were representative of n ≥ 3 for each target and tissue. ( B ) Relative expression levels of Caspase-8, RIPK1, and RIPK3 (and splenic MLKL; Fig. ) along the indicated tissue axes. Red datapoints indicate immunosignal intensities, and the overlaid dark blue line indicating the LOWESS best-fit along N = 20 axes per tissue. Best-fit curves are superimposed in the left-most column. The dashed line indicates the boundary between the splenic white pulp and the marginal zone. Data were representative of n > 3 mice per target per tissue. ( C ) Scatterplots where each dot represents a different cell ontology from the Tabula Muris dataset (Tabula Muris et al, ). The percent of cells within each ontology that expressed Mki67 , Ripk1 , or Ripk3 was plotted against that of Top2a . Pearson correlation coefficient values are shown. Related to Fig. . .

Article Snippet: Rat anti-mouse RIPK3 biotin-conjugated , This study , Derived from in-house clone 8G7 (available as Millipore Cat#MABC1595).

Techniques: Immunostaining, Expressing

Journal: EMBO Molecular Medicine

Article Title: An immunohistochemical atlas of necroptotic pathway expression

doi: 10.1038/s44321-024-00074-6

Figure Lengend Snippet: ( A ) Heatmap of cell ontologies from the Tabula Muris dataset (Tabula Muris et al, ). Left-most column depicts the tissue origin of each cell ontology. Other columns indicate the percent of cells within each ontology that expressed Top2a, Mki67 , Casp8 , Ripk1, Ripk3 , or Mlkl . Legend shows the color-to-tissue and the color-to-frequency scales. Cell ontologies of interest are annotated. ( B ) Micrograph of MLKL immunosignals from the wild-type mouse spleen. The white pulp (WP), marginal zone (MZ), and red pulp (RP) are annotated. Scale bar is 50 μm. Scatterplot shows relative expression levels of MLKL along the white pulp-to-red pulp axis. Red datapoints show immunosignal intensities and the overlaid dark blue line indicates the LOWESS best-fit along N = 20 axes from n = 1 mouse. Dashed line indicates the boundary between splenic white pulp and marginal zone. Data were representative of n > 3 mice. ( C , D ) Spatial transcriptomic data from (Moor et al, )) and (Ben-Moshe et al, ) showing the relative expression levels (arbitrary units; A.U.) of Caspase-8, RIPK1, RIPK3, or MLKL along the ileal crypt-to-villus axis ( C ) or the hepatic central vein-to-portal vein axis ( D ). ( E – G ) Spatial transcriptomic data on mouse spleen 12 days after Plasmodium berghei- infection. Panel ( E ) shows a uniform manifold approximation and projection (UMAP) of cell populations distinguished by unsupervised leiden clustering. Legend shows the color assigned to each population. Panel ( F ) shows the location of each cell cluster. Scale bar is 500 μm. Panel ( G ) shows the normalized expression for each gene product. Expression values for Casp8 , Ripk1 , Ripk3 , and Mlkl were summated to provide an index of “cluster pathway expression”, which was averaged to provide an index of “zone pathway expression”. Data were from n = 1 mouse.

Article Snippet: Rat anti-mouse RIPK3 biotin-conjugated , This study , Derived from in-house clone 8G7 (available as Millipore Cat#MABC1595).

Techniques: Expressing, Infection

Journal: EMBO Molecular Medicine

Article Title: An immunohistochemical atlas of necroptotic pathway expression

doi: 10.1038/s44321-024-00074-6

Figure Lengend Snippet: ( A ) Experimental design. ( B ) Core temperatures of vehicle- and TNF-injected mice ( n = 3 mice per group). ( C ) Immunosignals for cleaved Caspase-3 (cl. C3), Caspase-8, RIPK1, or RIPK3 from the spleen of vehicle- or TNF-injected mice. Insets show unidentified RIPK1 high cells that associate with apoptotic bodies in the splenic white pulp. In panels ( C , E , G , I ), the scale bars in zoomed-out images correspond to 100 μm, and the scale bars in zoomed-in images correspond to 10 μm. ( D ) Graph of white pulp area occupied by cleaved Caspase-3 + material in vehicle- and TNF-treated mice. Each red datapoint represents one white pulp lobule ( N = 20 lobules/mouse). Blue datapoints indicate the median value per mouse ( n = 3 mice/treatment). Black bars represent the mean value per group. * p < 0.05 by unpaired two-tailed t -test. ( E ) RIPK3 immunosignals in the colon of vehicle- or TNF-treated mice. ( F ) Best-fit curves of RIPK3 immunosignals along the crypt-to-tip axis from N = 10 axes per mouse ( n = 3 mice/group). *** p < 0.001 by multiple unpaired two-tailed t -test. ( G ) RIPK3 (pink) and smooth muscle actin (brown) immunosignals in intestinal submucosa of vehicle- or TNF-treated mice. Insets show vessel cross-sections. Arrowheads show RIPK3 + endothelial cells (endo). ( H ) Plot of RIPK3 signals per vessel. Each red datapoint represents one vessel ( N = 50 vessels/mouse). Blue datapoints indicate the median value per mouse ( n = 3 mice/treatment). Black bars represent the mean value per group. * p < 0.05 by unpaired two-tailed t -test. ( I ) RIPK3 immunosignals in the liver of vehicle- or TNF-treated mice. Central vein (CV), portal vein (PV) and Kupffer cell (Kpf). ( J ) Plot of RIPK3 signals per hepatocyte or Kupffer cell. Each transparent datapoint represents one cell ( N = 90 cells/mouse). Opaque datapoints indicate the median value per mouse ( n = 3 mice/treatment). Black bars represent the mean value per group. * p < 0.05 and ** p < 0.01 by unpaired two-tailed t -test. ( K ) Core temperatures of vehicle-, TNF- and Nec1s+TNF-injected wild-type mice ( n = 4–5 mice/treatment; one dot/mouse/time). Line indicates mean. X indicates a euthanized mouse due to its body temperature being <30 °C. ( L ) RIPK3 levels in serum from the mice in panel ( K ) or from untreated Ripk3 -/- mice. Data expressed as arbitrary optical density units (A.U.). One dot per mouse. Mean ± SEM is shown. * p < 0.05, ** p < 0.01 by one-way ANOVA with Tukey’s post hoc correction. .

Article Snippet: Rat anti-mouse RIPK3 biotin-conjugated , This study , Derived from in-house clone 8G7 (available as Millipore Cat#MABC1595).

Techniques: Injection, Two Tailed Test

Journal: EMBO Molecular Medicine

Article Title: An immunohistochemical atlas of necroptotic pathway expression

doi: 10.1038/s44321-024-00074-6

Figure Lengend Snippet: ( A ) Experimental design. ( B ) Bulk RNA sequencing was performed on indicated tissues. Heatmap depicts the log-fold-change in gene expression for antibiotic- versus water-treated mice. Each row represents a different mouse. The legend shows the color-to-value scale. ( C ) Immunoblots for the indicated proteins in the ileum and spleen of water- versus antibiotic-treated mice. Arrowheads indicate full-length proteins of interest. Coomassie staining of total protein content was used as a loading control. Data were representative of n = 7 mice per tissue per group. ( D ) Caspase-8, RIPK3, and RIPK3 immunosignals in the ileum of water- or antibiotic-treated mice. Arrowheads to cytosolic accumulations of RIPK1 and RIPK3 in epithelial cells at villi tips. Scale bars in lower magnification micrographs are 100 μm. Scale bars in insets are 10 μm. Data were representative of n = 7 mice per group. Related to Appendix Fig. . .

Article Snippet: Rat anti-mouse RIPK3 biotin-conjugated , This study , Derived from in-house clone 8G7 (available as Millipore Cat#MABC1595).

Techniques: RNA Sequencing Assay, Expressing, Western Blot, Staining, Control

Journal: EMBO Molecular Medicine

Article Title: An immunohistochemical atlas of necroptotic pathway expression

doi: 10.1038/s44321-024-00074-6

Figure Lengend Snippet: ( A ) Experimental design. ( B ) Ki67, Caspase-8, RIPK1, RIPK3, and MLKL immunosignals from adjacent sections of the naïve or NP-KLH-immunized mouse spleen. Arrowheads show a Ki67 + germinal center that co-stains for RIPK3, but not other members of the pathway. Representative of n > 3 mice per group. Scale bars in lower magnification micrographs are 500 μm. Scale bars in insets are 100 μm. Data were representative of n > 3 mice per group. ( C – J ) Ripk3 -/- or Ripk3 +/+ mice were immunized with NP-KLH and circulating NP-specific IgG 1 ( C ), circulating NP-specific IgM ( D ), splenic mature B cells ( E , F ), splenic NP-specific plasma cells ( G ), circulating low affinity NP-specific IgG 1 antibody ( H ), circulating high affinity NP-specific IgG 1 ( I ), and the ratio between circulating low-and-high affinity NP-specific antibody ( J ) were measured at the indicated day after immunization. Bars on graphs in ( C – J ) represent mean ± SEM. Each datapoint represents one mouse. ns non-significant by two-sided t -test with Welch’s correction.

Article Snippet: Rat anti-mouse RIPK3 biotin-conjugated , This study , Derived from in-house clone 8G7 (available as Millipore Cat#MABC1595).

Techniques:

Journal: EMBO Molecular Medicine

Article Title: An immunohistochemical atlas of necroptotic pathway expression

doi: 10.1038/s44321-024-00074-6

Figure Lengend Snippet: ( A ) Immunosignals of cleaved Caspase-3, Caspase-8, RIPK1, RIPK3, and MLKL in wild-type versus MLKL -/- or RIPK1 -/- , or CASP8 -/- CASP10 -/- MLKL -/- HT29 cells. Arrowheads indicate Caspase-8 + , RIPK1 + , RIPK3 + , and MLKL + puncta that are presumed to be necrosomes. Data were representative of n ≥ 2 for each protein and treatment. Scale bars in lower magnification micrographs are 10 μm. Scale bars in insets are 2 μm. ( B ) The percent of cells per treatment group that contain cytosolic necrosome-like puncta immunostained by the stipulated antibody. N = 1051–5630 cells were analysed per condition per stain. Data representative of n = 2 experiments. ( C ) The number of puncta per cell. N = 1000 cells per treatment group were analysed. Each datapoint represents one cell. The black bar indicates the mean value. **** p < 0.0001 by one-way ANOVA with Krukal–Wallis post hoc correction. Data representative of n = 2 experiments. Related to Appendix Figs. , and . .

Article Snippet: Rat anti-mouse RIPK3 biotin-conjugated , This study , Derived from in-house clone 8G7 (available as Millipore Cat#MABC1595).

Techniques: Staining

Journal: EMBO Molecular Medicine

Article Title: An immunohistochemical atlas of necroptotic pathway expression

doi: 10.1038/s44321-024-00074-6

Figure Lengend Snippet: ( A ) Approach used to insert the human RIPK3 coding sequence (CDS) into the mouse Ripk3 locus. ( B ) Immunoblot of spleen homogenates from Ripk3 +/+ , Ripk3 -/- , human RIPK3 ( RIPK3 KI/KI ) or hemizygous human RIPK3 ( Ripk3 + RIPK3 KI ) mice. GAPDH immunoblots are shown as loading controls. Each lane represents a different mouse. ( C ) Immunosignals produced by the anti-human RIPK3 (clone 37A7F) or anti-mouse RIPK3 (clone 8G7) antibodies on spleen sections from RIPK3 KI/KI , Ripk3 +/+ or Casp8 -/- Ripk1 -/- Ripk3 -/- . Data were representative of n ≥ 3 for each target and tissue. Scale bars are 500 μm.

Article Snippet: Rat anti-mouse RIPK3 biotin-conjugated , This study , Derived from in-house clone 8G7 (available as Millipore Cat#MABC1595).

Techniques: Sequencing, Western Blot, Produced

Journal: EMBO Molecular Medicine

Article Title: An immunohistochemical atlas of necroptotic pathway expression

doi: 10.1038/s44321-024-00074-6

Figure Lengend Snippet: ( A ) Study design. ( B ) Blinded histopathological (Robarts Histopathology Index; RHI) scores of disease activity in intestinal biopsies relative to their endoscopic grading of inflammation. Diamond indicates a sample that could not be formally scored, as it was solely comprised of neutrophilic exudate, but was given a pseudo-score of 15 that likely underrepresents the extent of disease activity in this biopsy. Biopsies scored in Panel B were matched to those used in panels ( C – E ) and Fig. (see Appendix Table for details). ( C ) Immunoblot of lysates from HT29 cells (red annotations) and intestinal biopsies from patients A-H (blue annotations). The fifth lane of each gel contained lysates from TSI-treated RIPK3 -/- or TSI-treated MLKL -/- cells (see source data for details). Patients A,C,E,G were non-IBD controls. Patients B and D had ulcerative colitis (UC). Patients F and H had Crohn’s disease (CD). The endoscopic grading of the biopsy site as “non-inflamed”, “marginally inflamed”, or “inflamed” is stipulated. Closed arrowheads indicate full-length form of proteins. Asterisks indicate active, phosphorylated forms of RIPK3 (pRIPK3) and MLKL (pMLKL). Open arrowheads indicate active, cleaved forms of Caspase-8, Caspase-10, and Caspase-3. GAPDH was used as a loading control. ( D ) Immunohistochemistry for Caspase-8 (clone B.925.8) on intestinal biopsies. Insets a–e show diffuse epithelial Caspase-8 in patient C. Insets f–j show mild clustering of epithelial Caspase-8 and insets k–o show more pronounced clustering of epithelial Caspase-8 in patient D (arrowheads). Scale bars in lower magnification micrographs are 500 μm. Scale bars in insets are 10 μm. ( E ) The number of Caspase-8 + puncta per 100 cells. Each datapoint represents one crypt. Whole slide scans with N = 20,246 cells from the ‘non-IBD patient C’ biopsy, N = 10,416 cells from the ‘non-inflamed patient D’ biopsy, and N = 30,799 cells from the ‘inflamed patient D’ biopsy were analysed. The black bar indicates the mean value. ** p < 0.01 by one-way ANOVA with Tukey’s post hoc correction. Related to Appendix Table Figs. 5; Appendix Fig. . .

Article Snippet: Rat anti-mouse RIPK3 biotin-conjugated , This study , Derived from in-house clone 8G7 (available as Millipore Cat#MABC1595).

Techniques: Histopathology, Activity Assay, Western Blot, Control, Immunohistochemistry

Journal: EMBO Molecular Medicine

Article Title: An immunohistochemical atlas of necroptotic pathway expression

doi: 10.1038/s44321-024-00074-6

Figure Lengend Snippet: Immunoblot of lysates from HT29 cells (red annotations) and intestinal biopsies from patients A-H (blue annotations). The fifth lane of each gel contained lysates from TSI-treated RIPK3 -/- or TSI-treated MLKL -/- cells (see source data for details). Patient J was a non-IBD control. Patient I had ulcerative colitis (UC). The endoscopic grading of the biopsy site as “non-inflamed”, “marginally inflamed”, or “inflamed” is stipulated. Closed arrowheads indicate full-length form of proteins. Asterisks indicate active, phosphorylated forms of RIPK3 (pRIPK3) and MLKL (pMLKL). Open arrowheads indicate active, cleaved forms of Caspase-10 and Caspase-3. GAPDH was used as a loading control.

Article Snippet: Rat anti-mouse RIPK3 biotin-conjugated , This study , Derived from in-house clone 8G7 (available as Millipore Cat#MABC1595).

Techniques: Western Blot, Control

Journal: EMBO Molecular Medicine

Article Title: An immunohistochemical atlas of necroptotic pathway expression

doi: 10.1038/s44321-024-00074-6

Figure Lengend Snippet: Immunohistochemistry for cleaved Caspase-3, Caspase-8 (clone B.925.8), RIPK1, RIPK3, and MLKL (clone EPR171514) on intestinal biopsies from the stipulated patients. Four representative micrographs per biopsy are shown (i-v). Open arrowheads indicate instances of epithelial apoptosis. Closed arrowheads indicate instances of epithelial Caspase-8 clustering. Scale bars are 10 μm. The location for each micrograph within the biopsy is indicated in Appendix Fig. .

Article Snippet: Rat anti-mouse RIPK3 biotin-conjugated , This study , Derived from in-house clone 8G7 (available as Millipore Cat#MABC1595).

Techniques: Immunohistochemistry

Journal: EMBO Molecular Medicine

Article Title: An immunohistochemical atlas of necroptotic pathway expression

doi: 10.1038/s44321-024-00074-6

Figure Lengend Snippet: Reagents and tools table

Article Snippet: Rat anti-mouse RIPK3 biotin-conjugated , This study , Derived from in-house clone 8G7 (available as Millipore Cat#MABC1595).

Techniques: Derivative Assay, Polymer, Plasmid Preparation, Blocking Assay, Membrane, Staining, RNA HS Assay, dsDNA Assay, Protease Inhibitor, Software, Imaging, Enzyme-linked Immunosorbent Assay

Journal: Cell Death & Disease

Article Title: Necroptosis does not drive disease pathogenesis in a mouse infective model of SARS-CoV-2 in vivo

doi: 10.1038/s41419-024-06471-6

Figure Lengend Snippet: A , B Mice were challenged intranasally with 10 4 TCID50 of a clinical SARS-CoV-2 isolate (P2) A Animals were euthanised at defined days post-infection (dpi) and lungs were collected for viral quantification by TCID50 assay. ( n = 5–12 mice per group, pooled from 2 independent experiments) B Daily percent weight change of infected animals compared to initial weight. ( n = 4–6 mice per group) C Lungs were collected and fixed for histological analysis at 2 and 4 dpi. Representative images of hematoxylin and eosin (H&E) and immunohistochemistry (IHC) stained lungs with SARS-CoV-2 nucleocapsid. Histological images are representative of at least 3 animals. Scale bar = 500 µm. D Western blot analysis of homogenized lungs from wild-type (WT) and MLK knockout ( Mlkl −/− ) animals 3 days after P2 infection. Samples were probed for phosphorylated MLKL (p-MLKL), MLKL, Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as a house-keeping gene, phosphorylated RIPK1 (p-RIPK1), phosphorylated RIPK3 (p-RIPK3), RIPK1 and RIPK3. Whole cell lysates of bone marrow derived macrophages treated with Tumor Necrosis Factor (TNF), Smac mimetic IAP antagonist and pan-caspase inhibitor were used as a positive controls for necroptosis ( n = 4 mice per group and are representative of 2 independent experiments).

Article Snippet: Proteins were transferred onto nitrocellulose membranes, blocked with either 5% skim milk (Devondale, Brunswick, Australia) or 5% BSA (for phospho-proteins) in PBS with 0.05% Tween-20 (PBST) for 1 h, and detected using the following primary antibodies: rat anti-MLKL (3H1; available from Merck Millipore, Bedford, MA), rabbit anti-p-MLKL (phospho S345) (EPR9515; Abcam, Cambridge, UK), rabbit anti-phospho-T231/S232 mouse RIPK3 (Genentech; clone GEN135-35-9 [ ]), rat anti-mouse RIPK3 (clone 8G7; produced in-house [ ], available from Millipore as MABC1595; rabbit anti-phospho-S166 mouse RIPK1 (Cell Signaling Technology 31122), rabbit anti-mouse or human RIPK1 (Cell Signaling Technology; clone D94C12), anti-SARS-CoV-2 nucleocapsid (1:4000, abcam ab271180) and rabbit anti-GAPDH (Cell Signaling Technology, 14C10).

Techniques: Infection, TCID50 Assay, Immunohistochemistry, Staining, Western Blot, Knock-Out, Derivative Assay

Journal: Cell Death & Disease

Article Title: Necroptosis does not drive disease pathogenesis in a mouse infective model of SARS-CoV-2 in vivo

doi: 10.1038/s41419-024-06471-6

Figure Lengend Snippet: A , B , C WT and Mlkl −/− mice were challenged intranasally with 10 4 TCID50 of SARS-CoV-2 P21 and monitored 3 days post infection for A lung viral burden using TCID50 assay B percent weight change compared to initial weight (n = 9 mice per group), and C the sum of twenty-six cytokines/chemokines expressed in supernatants of lung homogenates ( n = 4 mice per group; mean ± SD of each cytokine are shown). D Western blot analysis of homogenized lungs from mock (intranasal DMEM inoculation), wild-type (WT) and MLK knockout ( Mlkl −/− ) animals 3 days after intranasal P21 infection (10,000 TCID50). Samples were probed for phosphorylated MLKL (p-MLKL), MLKL, Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as a house-keeping gene, phosphorylated RIPK1 (p-RIPK1), phosphorylated RIPK3 (p-RIPK3), RIPK1, RIPK3 and SARS-CoV-2 nucleocapsid. Whole cell lysates of bone marrow derived macrophages treated with Tumor Necrosis Factor (TNF), Smac mimetic IAP antagonist (LCL-161) and pan-caspase inhibitor (IDN-6556) were used as positive controls for necroptosis ( n = 2 mice per group and are representative of 2 independent experiments). E Representative images of hematoxylin and eosin (H&E) and immunohistochemistry (IHC) stained lungs with SARS-CoV-2 nucleocapsid. Mice were challenged intranasally with 10 4 TCID50 of SARS-CoV-2 P21 and lungs were collected and fixed for histological analysis at 3 dpi. Histological images are representative of at least 3 animals. Scale bars = 500 µm. Unpaired two-tailed student’s t -test ( B ) after performing log 10 transformation ( A ) and one-way ANOVA with multiple comparisons ( C ).

Article Snippet: Proteins were transferred onto nitrocellulose membranes, blocked with either 5% skim milk (Devondale, Brunswick, Australia) or 5% BSA (for phospho-proteins) in PBS with 0.05% Tween-20 (PBST) for 1 h, and detected using the following primary antibodies: rat anti-MLKL (3H1; available from Merck Millipore, Bedford, MA), rabbit anti-p-MLKL (phospho S345) (EPR9515; Abcam, Cambridge, UK), rabbit anti-phospho-T231/S232 mouse RIPK3 (Genentech; clone GEN135-35-9 [ ]), rat anti-mouse RIPK3 (clone 8G7; produced in-house [ ], available from Millipore as MABC1595; rabbit anti-phospho-S166 mouse RIPK1 (Cell Signaling Technology 31122), rabbit anti-mouse or human RIPK1 (Cell Signaling Technology; clone D94C12), anti-SARS-CoV-2 nucleocapsid (1:4000, abcam ab271180) and rabbit anti-GAPDH (Cell Signaling Technology, 14C10).

Techniques: Infection, TCID50 Assay, Western Blot, Knock-Out, Derivative Assay, Immunohistochemistry, Staining, Two Tailed Test, Transformation Assay

Journal: Biochemical Journal

Article Title: The VEGFR/PDGFR tyrosine kinase inhibitor, ABT-869, blocks necroptosis by targeting RIPK1 kinase

doi: 10.1042/BCJ20230035

Figure Lengend Snippet: ( A ) Schematic of the necroptosis pathway. TNF (T) activates TNFR1, the Smac-mimetic Compound A (S) blocks cIAP activity and the pan-caspase inhibitor Q-VD-OPh (Q) blocks caspase-8 activity. This TSQ stimulus results in activation of RIPK1 and RIPK3, and subsequent phosphorylation and activation of MLKL, which causes MLKL-mediated membrane disruption and cell death. ( B ) Schematic of the constitutively activated mouse MLKL mutant, Q343A. Expression of MLKL Q343A using doxycycline causes cell death in the absence of upstream necroptotic stimuli. This enabled a cell-based phenotypic screen for small molecules that modulate necroptosis at the level or downstream of MLKL activation. The skull and crossbones image (Mycomorphbox_Deadly.png; by Sven Manguard) in ( A , B ) was used under a Creative Commons Attribution-Share Alike 4.0 license. ( C ) Schematic of the cell-based phenotypic screen. A total of 5632 compounds from the WEHI small molecule library along with 40 kinase inhibitors were screened against wild-type or Mlkl −/− mouse dermal fibroblast (MDF) cells expressing the MLKL Q343A mutant. The ability of the small molecules to inhibit cell death was measured by CellTiter-Glo cell viability assays. ABT-869, a VEGF and PDGF receptor tyrosine kinase inhibitor, was identified as a hit. See also Supplementary Figure S1A. ( D ) Chemical structure of ABT-869 and its analogue WEHI-615. ( E ) Wild-type mouse dermal fibroblast (MDF) cells expressing the doxycycline-inducible MLKL Q343A mutant to trigger constitutive necroptosis were treated with DMSO alone, doxycycline (Dox; 1 µg/ml) and DMSO, or Dox and ABT-869 (1 µM). Cell viability was quantified by CellTiter-Glo. Data represent the mean of ≥2 technical replicates from a single experiment, with individual data points shown. See also Supplementary Figure S1A. ( F ) Mlkl −/− mouse dermal fibroblast (MDF) cells expressing the doxycycline-inducible MLKL Q343A mutant to trigger constitutive necroptosis were treated with DMSO alone, doxycycline (Dox; 1 µg/ml) and DMSO, or Dox and ABT-869 (1 µM). Cell viability was quantified by CellTiter-Glo. Data represent the mean of ≥2 technical replicates from a single experiment, with individual data points shown. See also Supplementary Figure S1A. ( G ) Wild-type mouse dermal fibroblast (MDF) cells were stimulated with TSQ (TNF, Smac-mimetic, Q-VD-OPh) to induce necroptosis and treated with increasing concentrations of ABT-869 or WEHI-615. Cell death was quantified by propidium iodide (PI) staining using flow cytometry. Data represent the mean of n = 4 independent experiments and errors bars represent SEM.

Article Snippet: Mouse RIPK3 (phosphorylation time course) , Rat anti-mouse RIPK3 clone 8G7 , Produced in-house [ ], available from Merck Millipore , cat #MABC1595 , 1 : 1000.

Techniques: Activity Assay, Activation Assay, Mutagenesis, Expressing, Staining, Flow Cytometry

Journal: Biochemical Journal

Article Title: The VEGFR/PDGFR tyrosine kinase inhibitor, ABT-869, blocks necroptosis by targeting RIPK1 kinase

doi: 10.1042/BCJ20230035

Figure Lengend Snippet: ( A , B ) Wild-type mouse dermal fibroblast (MDF) cells were treated with increasing concentrations of ABT-869 or control compounds, RIPK3 inhibitors GSK′872 and GSK′843, DMSO alone or left untreated (UT) for 1 h then stimulated with TSQ (TNF, Smac-mimetic, Q-VD-OPh) ( A ) or TSZ (TNF, Smac-mimetic, z-VAD-fmk) ( B ) for 24 h to induce necroptosis. Cell death was quantified by propidium iodide (PI) staining using flow cytometry. Data represent the mean of n = 3 ( A ) or n = 4 ( B ) independent experiments and error bars represent SEM. ( C – F ) Human U937 cells were treated with increasing concentrations of ABT-869 or control compounds, MLKL inhibitor NSA and RIPK1 inhibitor GSK′481, DMSO alone or left untreated (UT) for 1 h then stimulated with TSQ (TNF, Smac-mimetic, Q-VD-OPh) for 48 h ( C ) or TSI (TNF, Smac-mimetic, IDN-6556) for 24 h ( E ) to induce necroptosis. Parallel experiments were performed to assess protection of TSQ ( D ) or TSI ( F ) induced death in the presence of the ABT-869 analogue, WEHI-615. Cell death was monitored by SPY505 (live cells) and propidium iodide (PI; dead cells) uptake using IncuCyte live cell imaging. One representative result shown from n = 4 ( C , D ) or n = 3 ( E , F ) independent experiments. See also Supplementary Figure S2A–H.

Article Snippet: Mouse RIPK3 (phosphorylation time course) , Rat anti-mouse RIPK3 clone 8G7 , Produced in-house [ ], available from Merck Millipore , cat #MABC1595 , 1 : 1000.

Techniques: Staining, Flow Cytometry, Live Cell Imaging

Journal: Biochemical Journal

Article Title: The VEGFR/PDGFR tyrosine kinase inhibitor, ABT-869, blocks necroptosis by targeting RIPK1 kinase

doi: 10.1042/BCJ20230035

Figure Lengend Snippet: ( A ) Binding affinities ( K D ) of ABT-869 and WEHI-615 for human full-length MLKL, RIPK1 kinase domain and RIPK3 kinase domain measured by competition binding assays from the DiscoverX KINOME scan platform using the Kd ELECT service. Each value is the mean of two replicates. ( B – D ) Cellular Thermal Shift Assays (CETSA) in mouse and human cells. Mlkl −/− mouse dermal fibroblast (MDF) cells expressing MLKL Q343A ( B ), wild-type MDF cells ( C ) and human U937 cells ( D ) were treated with DMSO, ABT-869, WEHI-615, RIPK1 inhibitor Nec-1s, RIPK3 inhibitor GSK′872 or human RIPK1 inhibitor GSK′481 (all 20 µM). Cells were subjected to an increasing temperature gradient focused around the melting temperature of the protein of interest. Following the separation of soluble and insoluble proteins, the remaining soluble proteins were detected by Western blot. Red asterisks denote protein standards. One representative result shown from n = 3 ( B , C ) or n = 2–3 ( D ) independent experiments. See also Supplementary Figure S3A–C.

Article Snippet: Mouse RIPK3 (phosphorylation time course) , Rat anti-mouse RIPK3 clone 8G7 , Produced in-house [ ], available from Merck Millipore , cat #MABC1595 , 1 : 1000.

Techniques: Binding Assay, Expressing, Western Blot

Journal: Biochemical Journal

Article Title: The VEGFR/PDGFR tyrosine kinase inhibitor, ABT-869, blocks necroptosis by targeting RIPK1 kinase

doi: 10.1042/BCJ20230035

Figure Lengend Snippet: Thermal Shift Assays (TSA) with mouse and human RIPK1 and RIPK3 kinase domains. Increasing concentrations of ABT-869 or WEHI-615 were tested for their ability to alter the melting temperature ( T M ) of mouse RIPK1 (9.5 µg) ( A , B ), human RIPK1 (12 µg) ( C , D ), mouse RIPK3 (10 µg) ( E , F ) and human RIPK3 (6.5 µg) ( G , H ) compared with the positive controls Compound 2 for mouse RIPK1, GSK′481 for human RIPK1 and GSK′872 for mouse and human RIPK3 (all 30 µM). Data represent the mean of n = 3 independent experiments and error bars represent SEM. See also Supplementary Figure S4A–H.

Article Snippet: Mouse RIPK3 (phosphorylation time course) , Rat anti-mouse RIPK3 clone 8G7 , Produced in-house [ ], available from Merck Millipore , cat #MABC1595 , 1 : 1000.

Techniques:

Journal: Biochemical Journal

Article Title: The VEGFR/PDGFR tyrosine kinase inhibitor, ABT-869, blocks necroptosis by targeting RIPK1 kinase

doi: 10.1042/BCJ20230035

Figure Lengend Snippet: ( A – H ) In vitro phosphorylation assays with mouse and human RIPK1 and RIPK3 kinase domains measured by ADP-Glo Kinase Assays. Increasing concentrations of ABT-869 or WEHI-615 were tested for their ability to inhibit the autophosphorylation (IC 50 ) of mouse RIPK1 (200 nM) ( A , B ), human RIPK1 (200 nM) ( C , D ), mouse RIPK3 (10 nM) ( E , F ) and human RIPK3 (10 nM) ( G , H ). Data represent the mean of n = 3 ( A , B , E , F ) or n = 2 ( C , D , G , H ) independent experiments and error bars represent SEM. ( I ) Cellular phosphorylation assays. Wild-type mouse dermal fibroblast (MDF) cells were treated with DMSO, ABT-869, WEHI-615, RIPK1 inhibitor Nec-1s or RIPK3 inhibitor GSK′872 for 2 h then stimulated with TSI (TNF, Smac-mimetic, IDN-6556) for 2 h to induce autophosphorylation of RIPK1 and RIPK3. Ripk1 −/− Mlkl −/− MDF cells and Ripk3 −/− MDF cells were included as controls. Phospho-RIPK1 and phospho-RIPK3 protein levels were detected from whole cell lysates by Western blot. Red asterisks denote protein standards. One representative result shown from n = 3 independent experiments. See also Supplementary Figure S5A–C.

Article Snippet: Mouse RIPK3 (phosphorylation time course) , Rat anti-mouse RIPK3 clone 8G7 , Produced in-house [ ], available from Merck Millipore , cat #MABC1595 , 1 : 1000.

Techniques: In Vitro, Western Blot

Journal: Biochemical Journal

Article Title: The VEGFR/PDGFR tyrosine kinase inhibitor, ABT-869, blocks necroptosis by targeting RIPK1 kinase

doi: 10.1042/BCJ20230035

Figure Lengend Snippet:

Article Snippet: Mouse RIPK3 (phosphorylation time course) , Rat anti-mouse RIPK3 clone 8G7 , Produced in-house [ ], available from Merck Millipore , cat #MABC1595 , 1 : 1000.

Techniques: Western Blot, Produced, Transduction

Journal: Biochemical Journal

Article Title: The VEGFR/PDGFR tyrosine kinase inhibitor, ABT-869, blocks necroptosis by targeting RIPK1 kinase

doi: 10.1042/BCJ20230035

Figure Lengend Snippet:

Article Snippet: Mouse RIPK3 (phosphorylation time course) , Rat anti-mouse RIPK3 clone 8G7 , Produced in-house [ ], available from Merck Millipore , cat #MABC1595 , 1 : 1000.

Techniques: